Trevi Therapeutics Inc. (TRVI) Fundamentals

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. It is involved in developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, or IPF, and levodopa-induced dyskinesia, or LID, in patients with Parkinson's disease.
SHARE INFORMATION
Market Cap$ 114,452,825
Shares Outstanding59,922,945
Float42,930,414
Percent Float71.64%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -1.50
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions67
Institutional Holdings Date2022-11-30
Institutional Bought Previous 3 Months23,538,440
Institutional Holdings Percent73.7%
Institutional Sold Previous 3 Months5,102,932
Insider Holdings Date2022-10-31
Insider Bought Previous 3 Months39,500
Insider Holdings Percent1.7
Insider Sold Previous 3 Months-
Insider Shares Owned976,405
TRADING INFO
52 Week High$ 4.68
52 Week Low$ 0.46
52 Week High Change$ 92.89
21 Day Moving Average$ 1.9729
21 Day Extended Moving Average$ 1.953
50 Day Moving Average$ 1.8891
50 Day Extended Moving Average$ 2.1021
200 Day Moving Average$ 2.4408
200 Day Extended Moving Average$ 2.3039
10 Day Average Volume69,475
20 Day Average Volume65,768
30 Day Average Volume63,187
50 Day Average Volume220,122
Alpha0.014282
Beta0.7145
Standard Deviation0.477824
R20.007167
7 Day Price Change$ 0.09
7 Day Percent Change4.95%
21 Day Price Change$ -0.02
21 Day Percent Change-1.04%
30 Day Price Change$ -0.09
30 Day Percent Change-4.5%
Month to Date Price Change$ 0.03
Month to Date Percent Change1.6%
Quarter to Date Price Change$ 0.37
Quarter to Date Percent Change24.03%
180 Day Price Change$ -0.52
180 Day Percent Change-21.4%
200 Day Price Change$ -0.30
200 Day Percent Change-13.57%
Year to Date Price Change$ 1.13
Year to Date Percent Change144.18%

Trevi Therapeutics Inc. (TRVI) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.00
Total Debt To Equity0.10
Int Coverage-24.90
Current Ratio8.70
Leverage Ratio1.40
Quick Ratio8.60
Long Term Debt To Capital0.03
VALUATION MEASURES
PE Ratio-2.50
Enterprise Value$ -2,086,864
Price to Sales0.00
Price to Free Cash-4.00
PE High Last 5 Years0.00
Price To Book1.00
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book1.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-40.22
Return on Equity-53.04
Return on Capital-43.03

Trevi Therapeutics Inc. (TRVI) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOJennifer L. Good
Emplyoees23
Last AuditUE
CIK0001563880
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address195 Church Street
14th Floor
New Haven, CT 6510
Websitehttps://www.trevitherapeutics.com
Facsimile-
Telephone+1 203 304-2499
Email-


Your Recent History
NASDAQ
TRVI
Trevi Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.